Whole-genome sequencing is being explored for its potential clinical application in treating solid tumors, including its use in precision oncology. The technology's readiness for clinical use in certain types of cancer, such as breast cancer, is being questioned, while it is being introduced as a standard of care for glioma patients in some centers. Research is also investigating the benefits of whole-genome sequencing in pediatric cancer cases and its comparison to other sequencing methods.